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A B S T R A C T
This study: 1) compared cognitive functioning between individuals with chronic (>1 year) spinal cord injury
(SCI) and non-injured controls and, 2) assessed associations between symptoms of autonomic dysreflexia and
orthostatic hypotension with cognitive functioning in SCI participants with a history of unstable blood pressure
(BP). Thirty-two individuals with SCI (C4–L2, American Spinal Injury Association Impairment Scale A-D) and
thirty age, sex-matched non-injured controls participated in this study. Participants completed a motor-free
neuropsychological test battery assessing 1) memory, 2) attention/concentration/psychomotor speed and, 3)
executive function.
Nineteen participants with SCI who had injuries ≥T6 and a history of unstable BP also completed the
Autonomic Dysfunction Following Spinal Cord Injury (ADFSCI) questionnaire. Cognitive function was sig-
nificantly lower in people with SCI across measures of memory and executive function compared to non-injured
controls. Significant, moderate-to-large associations were observed between cumulative (frequency x severity)
orthostatic hypotension and total BP instability symptoms scores, with measures of attention/concentration/
psychomotor speed and executive function. These data demonstrate a 10 – 65% reduced performance across
specific realms of cognitive functioning in individuals with SCI relative to non-injured controls. Furthermore,
cumulative subjective scores for symptoms of unstable BP were associated with diverse cognitive deficits. These
findings, in individuals without co-occurring traumatic brain injury, imply cardiovascular dysregulation plays a
role in cognitive deficits observed in this population.
1. Introduction
Cognitive dysfunction after spinal cord injury (SCI) is widespread,
with 10–60% of this population being afflicted [1]. Declines in cogni-
tion after SCI are diverse affecting various domains such as abstract
reasoning, memory storage and retrieval, attention, concentration, and
problem solving [1–4]. In the general population poor cognitive func-
tion is associated with unemployment and lower work performance,
reduced health literacy [5], depression [6], and increased mortality [7].
Impaired cognition presents in the sub-acute phase post-SCI, which may
impede functional rehabilitation, and worsens over time [8]. Reduced
cognitive performance has been demonstrated in chronically-injured
SCI individuals compared to age-matched non-injured controls [9].
However, no significant differences were noted in cognitive perfor-
mance when compared to healthy controls that were ~ 20 years older.
Thus, it has been argued that SCI may represent a model of premature
aging [10]. The reasons for cognitive impairments in this population
are multifactorial [1]. Up to ~60% of individuals with a high-level SCI
sustain a concomitant traumatic brain injury (TBI) [11]. Recently, we
and others have highlighted that autonomic cardiovascular dysfunc-
tions are contributing factors towards cognitive decline after SCI
[1,12,13].
Autonomic dysfunction following upper-thoracic or cervical SCI is
widespread, and are often reported to be of a higher importance to
those living with this condition than restoring lower extremity motor
function [14]. From a cardiovascular perspective, individuals with
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high-level SCI [at or above the 6th thoracic segment (≥T6)] experience
extreme BP fluctuations that manifest as periods of transient hypoten-
sion (orthostatic hypotension) and hypertension (i.e. autonomic dys-
reflexia) [15]. Orthostatic hypotension is defined as a decrease in sys-
tolic or diastolic BP of more than 20 or 10 mmHg, respectively, within
three minutes of becoming upright in posture [16]. Orthostatic hypo-
tension assessed at midlife has been shown to be independently asso-
ciated with incident dementia and ischemic stroke over a twenty-five
year follow-up [17]. Studies in non-disabled, hypotensive individuals
have shown decreased ability in sustaining attention and working
memory [18–21]. The loss of supraspinal sympathetic nervous system
input following high-level SCI leads to systemic hypotension, which is
worsened with postural stress and triggered by an impaired hemody-
namic balance [22]. SCI individuals who experience hypotensive epi-
sodes have previously shown significantly impaired cognitive function
in the domains of memory, executive function, and moderate impair-
ment in attention and processing speed [23].
Another form of cardiovascular dysfunction is autonomic dysre-
flexia, which is experienced by over 90% of individuals with chronic
high-level SCI [24,25]. It has been speculated that autonomic dysre-
flexia contributes to a variety of clinical conditions, including cognitive
dysfunction, which is potentially mediated by impairments in cere-
brovascular function [26]. During episodes of autonomic dysreflexia,
BP can rise as high as 300 mmHg, which can result in stroke, other
cerebrovascular trauma, or even death [27]. We have reported as many
as 41 autonomic dysreflexia events occur each day (mean = 11/day) in
individuals with high-level SCI [28]. Recent evidence in pre-clinical
models demonstrates diverse cerebrovascular impairments with chronic
exposure to repetitive episodes of transient hypertension following SCI
[29]. Chronic hypertension in non-disabled individuals is strongly and
consistently associated with cognitive decline [30]. Evidence demon-
strates cognitive decline with chronic hypertension essentially en-
compasses the entire spectrum of cognitive domains including learning
and memory, attention, abstract reasoning, executive function, as well
as visuospatial, perceptual and psychomotor abilities [31–33]. In ad-
dition, a number of recent reviews have documented that hypertension
is a causal factor in the development of vascular dementia, as well as
mild cognitive impairments [34,35]. To date no study has examined the
associations between symptoms of transient episodes of hypotension
and hypertension with cognitive functioning in individuals with SCI.
Understanding these associations may help identify interventional tar-
gets for reducing cognitive impairment in this population.
The aims of this study were to: 1) compare cognitive function be-
tween individuals with chronic SCI and age and sex-matched non-in-
jured controls, and 2) test the association between orthostatic hypo-
tension, autonomic dysreflexia and cognitive function in individuals
with SCI ≥T6. We hypothesized that those with SCI would have im-
paired cognitive function across several domains compared to non-in-
jured controls and that symptoms of orthostatic hypotension and au-
tonomic dysreflexia would be associated with a range of cognitive
deficits.
2. Methods
Participants included 32 individuals with chronic SCI (>1 year) and
30 aged- and sex-matched non-injured controls. The level and com-
pleteness of injury was confirmed using an International Standards for
Neurological Classification of SCI (ISNCSCI) examination performed by
a trained physician (AVK), which provided an American Spinal Injury
Association Impairment Scale (AIS) grade [36]. Participants had no
history of cardiovascular disease or TBI, or hearing or language issues
that may affect the ability to follow instructions. Demographic in-
formation of participants is presented in Table 1. Informed consent was
obtained from all participants and the protocol was approved by the
University of British Columbia Clinical Research Ethics Board. This
study was completed over one visit, which included the ISNCSCI
assessment, followed by the completion of a self-reported questionnaire
to quantify BP instability and a motor-free neurocognitive assessment
battery. Participants with SCI were recruited first. Individuals with SCI
responded to recruitment flyers advertised at inpatient (GF Strong Re-
habilitation C1enter) and outpatient (Blusson Spinal Cord C1enter)
treatment facilities in greater Vancouver. Non-injured controls were
recruited from the local community and hospital personnel via posters
and social-media platforms.
2.1. Assessment of blood pressure instability
For participants with injuries ≥T6, information about symptoms of
BP instability were captured through an adapted version of the
Autonomic Dysfunction Following SCI (ADFSCI) questionnaire, which
was developed for use in both clinical and research settings [28]. The
ADFSCI was designed using the Delphi technique by a consortium of
experts with experience in treating individuals with SCI. Previous re-
search has demonstrated this questionnaire to have almost perfect test-
retest reliability and adequate sensitivity to detect the frequency and
severity of autonomic dysreflexia episodes, compared to 24 h ambula-
tory blood pressure monitoring (ABPM) [28]. The questionnaire asked
participants to rate the frequency and severity of specific symptoms
related to orthostatic hypotension (six items: dizziness, nausea, fatigue,
passing out, lightheadedness, blurred vision) and autonomic dysreflexia
(three items: sweating, headaches, goosebumps) experienced on a daily
basis. Each item was answered using a 4-point Likert scale with the
following anchors: symptom frequency = “Frequently”, “Sometimes”,
“Rarely” and “Never”, and symptom severity = “Severely”, “Moderately”,
“Mildly” and “Never”. Symptoms of BP instability were assessed in
participants with an SCI ≥T6 (n = =19), with a history of unstable BP
fluctuations due to decentralized sympathetic control of splanchnic and
lower extremity vasculature [15]. Given the greater prevalence of au-
tonomic dysreflexia and orthostatic hypotension with more severe in-
juries, only motor-complete injuries (AIS A and B) were included in this
component of the study.
For the frequency of each symptom, participants who answered
“Never” were given a score of 0, “Rarely” or “Sometimes” were given a
score of 1, and “Frequently” received a score of 2. The severity of each
orthostatic hypotension and autonomic dysreflexia symptom was
Table 1
Demographic and injury characteristics for non-injured controls and partici-
pants with spinal cord injury.
Control-AB (n = 30) SCI (n = 32) P value
Demographics
Age (years) 44 ± 11 39 ± 11 0.093
Sex: n (%)
Male 23 (77%) 25 (78%) 1.000a
Female 7 (23%) 7 (22%)
BDI-II 3.9 ± 5.0 10.8 ± 9.3 <0.001
SYS (mmHg) 126 ± 10 107 ± 7 <0.001
DIA (mmHg) 77 ± 9 62 ± 5 <0.001
Injury characteristics
Injury Level; n (%)
Cervical – 15 (47%) –
Thoracic – 16 (50%) –
Lumbar – 1 (3%) –
AIS n (%)
Motor-complete (A or B) – 23 (72%) –
Motor-incomplete (C or D) – 9 (28%) –
TSI (years) – 13 ± 10 –
Values are displayed as mean±SD for numerical variables and percentages for
categorical variables. a For frequency data, two-sample tests for equality of
proportions without continuity correction were performed.
Abbreviations: AIS, American Spinal Injury Association Impairment Scale; BDI-
II, Beck Depression Inventory; DIA, diastolic blood pressure; SYS, systolic blood
pressure; TSI, Time Since Injury.
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scored similarly, with “Never” receiving a score of 0, “Moderately” or
“Mildly” as 1, and “Severely” as a score of 2. Total frequency and se-
verity scores were calculated for orthostatic hypotension, autonomic
dysreflexia and total (representing absolute BP instability) symptoms by
summing the scores across corresponding symptoms to create arbitrary
units. The cumulative score (used in Table 3) was calculated by mul-
tiplying the numerical values of frequency by severity, for orthostatic
hypotension, autonomic dysreflexia and total symptoms, respectively.
To minimize the amount of comparisons and to reduce the likelihood of
type-II error we felt it pertinent to only present cumulative scores rather
than both frequency and severity values.
2.2. Neurocognitive test battery
All neurocognitive assessments were conducted by an experienced
research coordinator and required approximately 60 min. Demographic
characteristics were gathered and seated BP measured (Dinamap Pro
300V2; General Electric). The following cognitive and behavioral
motor-free tests were performed in a fixed order: Rey Auditory Verbal
Learning Test (RAVLT), Forward and Backward Digit Span Test (DS),
Symbol Digit Modalities Test (SDMT), Verbal Trail Making Test A and B
(TMT), Stroop Test, Controlled Oral Word Association Test (COWAT),
and Beck Depression Inventory. These tests assessed the following
subdomains of: 1) memory: Rey Auditory Verbal Learning Test (RAVLT)
[37]; 2) attention/concentration/psychomotor speed: Forward and Back-
ward DS [37], Trail Making Test (TMT) part A [38], and Stroop Test
[39]; 3) executive function: Trail Making Test (TMT) part B [38], Symbol
Digit Modalities Test (SDMT) [37], and Controlled Oral Word Asso-
ciation Test (COWAT) [37]. This comprehensive neurocognitive test
battery has been shown to be reliable in individuals with SCI [40]. All
tests were delivered orally to account for motor function disparities
between individuals with higher and lower level SCI and non-injured
controls. Symptoms of depression were also assessed using the Beck
Depression Inventory (BDI-II) [41].
2.3. Statistical analysis
The demographic and injury characteristics of the groups were de-
scribed as means± standard deviations or percentages. Following an
assessment of normality (Levene's Test for Equality of Variances), dif-
ferences in demographic variables between groups (control-AB vs. SCI)
were assessed using parametric (i.e., independent sample t-tests) or
nonparametric comparisons (i.e., Mann-Whitney U test) for continuous
numerical variables (age, BDI-II and BP) and a two-sample tests for
equality of proportions without continuity correction for categorical
variables (sex). The neurocognitive function data were described as
means± standard deviations, along with the mean differences between
the groups (with upper and lower confidence intervals). Independent
sample t-tests were performed and a standardized difference (Cohen's
D) calculated, with the following thresholds: small (d > 0.20), medium
(d > 0.50) and large (d > 0.80). Spearman Rank Correlation
Coefficients were employed to examine the associations between cu-
mulative (frequency x severity) symptom scores for specific conditions
(autonomic dysreflexia and orthostatic hypotension) and total BP in-
stability with neurocognitive test outcomes in a subsample of partici-
pants with SCI ≥T6. The following thresholds will be used to quantify
the magnitude of associations: small (Rs > 0.1), moderate (Rs >0.3),
large (Rs > 0.5), very large (Rs > 0.7). The threshold for statistical
significance was set a priori at p < 0.05.
3. Results
Participant characteristics are summarized in Table 1, which shows
that there were no significant differences between SCI and non-injured
controls with respect to age (p = 0.093) and sex (p = 0.999). On
average, individuals with SCI scored significantly higher on the BDI-II
(p <0.001) and had lower resting systolic and diastolic BP relative to
the non-injured controls (Table 1).
3.1. Differences in neurocognitive test performance between individuals with
spinal cord injury and age, sex matched non-injured controls
Compared to the non-injured control group; individuals with SCI
had impairments in memory and executive function domains (Table 2). In
the memory domain, individuals with SCI recalled ~5 (10%) fewer
words in total and recalled ~2 (20%) fewer words after a long delay
during the RAVLT compared to the control group. No significant dif-
ferences were found between SCI and the control group in the domain
of attention/concentration/psychomotor speed. In the domain of executive
function, individuals with SCI took approximately twice as long as
controls to complete the TMT task. Moreover, non-injured controls
scored ~12% higher in the modified SDMT (i.e. de-coded 11% more
Table 2
Neurocognitive function outcomes for non-injured controls and participants with spinal cord injury.
Domain and test Control-AB (n = 30) SCI (n = 32) Mean difference (lower and upper 95% CI) Cohen's D P value
Memory
RAVLT, total acquisition (n)* 51.8 ± 9.8 46.9 ± 8.2 −4.9 (−9.5, −0.4) 0.54 0.034
RAVLT, recall after interference (n)* 10.4 ± 3.1 8.9 ± 2.9 −1.5 (−3.0, 0.1) 0.50 0.059
RAVLT, loss after interference (n)† 2.0 ± 1.8 2.5 ± 1.7 0.5 (−0.4, 1.4) −0.29 0.242
RAVLT, long delay free recall (n)* 10.6 ± 3.2 8.7 ± 2.6 −1.9 (−3.4, −0.5) 0.65 0.010
RAVLT, recognition (n)* 13.7 ± 1.7 13.0 ± 1.7 −0.7 (−1.6, 0.1) 0.41 0.097
Attention/Concentration/Psychomotor Speed
DS, forward (n)* 9.1 ± 2.5 8.5 ± 2.2 −0.6 (−1.8, 0.6) 0.25 0.341
DS, backward (n)* 5.8 ± 2.1 4.8 ± 2.5 −1.0 (−2.2, 0.2) 0.43 0.096
DS, score (n)* 14.9 ± 4.2 13.3 ± 4.2 −1.6 (−3.7, 0.6) 0.38 0.151
TMT, A (s) 7.2 ± 2.5 7.3 ± 2.0 0.1 (−1.0, 1.3) −0.04 0.773
Stroop Test-P2 Time (s) 50.8 ± 11.3 51.9 ± 9.7 1.1 (−4.2, 6.4) −0.10 0.680
Stroop Test-P3 Time (s) 85.2 ± 18.7 84.5 ± 15.9 −0.7 (−9.5, 8.1) 0.04 0.876
Stroop Test-P3-P2 (s) 34.4 ± 14.4 32.6 ± 11.8 −1.8 (−8.5, 4.9) 0.14 0.593
Executive Function
TMT, B (s) 26.6 ± 14.2 45.7 ± 40.3 19.1 (3.9, 34.5) −0.63 0.016
TMT, B-A (s) 19.4 ± 13.9 38.4 ± 39.6 19.0 (4.0, 34.1) −0.64 0.016
SDMT (n)* 59.9 ± 11.7 53.3 ± 9.2 −6.6 (−12.0, −1.3) 0.63 0.015
COWAT (n)* 44.7 ± 12.6 40.0 ± 11.7 −4.7 (−10.9, 1.5) 0.39 0.135
Values are shown as Mean± S.D. P values and 95% CI's for each metric were reported appropriately depending on the Levene's test for equality of variances. *Higher
score indicates better performance. † Loss after interference calculated as trial 5 score minus trial 6 score. Abbreviations: CI, confidence interval; COWAT, Controlled
Oral Word Association Test; DS, Digit Span; RAVLT, Rey Auditory Verbal Learning Test; SDMT, Symbol Digit Modalities Test; TMT, Trail Making Test.
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symbols to numbers) (Table 2).
3.2. Symptoms of blood pressure instability and neurocognitive test
performance in individuals with cervical and upper-thoracic spinal cord
injury
The associations between neurocognitive test performance and self-
reported cumulative burden of autonomic dysreflexia, orthostatic hy-
potension and total BP instability are presented in Table 3. These as-
sociations were performed in individuals with SCI ≥T6, with a history
of unstable BP control. No significant associations were observed within
the memory domain. Cumulative orthostatic hypotension and total BP
instability scores displayed moderate, significant positive associations
in the attention/concentration/psychomotor speed and executive function
domains. More specifically, individuals with higher cumulative ortho-
static hypotension and total symptoms took longer to complete the
Stroop Test P2 & P3, TMT B, as well as TMT B-A. A moderate, non-
significant (P = 0.057), positive association was seen between auto-
nomic dysreflexia symptoms and the time to count from 1 to 25. No
significant associations were observed with cumulative symptoms of
autonomic dysreflexia and neurocognitive test performance.
4. Discussion
This study, utilizing a comprehensive and reliable neurocognitive
test battery, demonstrates that cognitive function is impaired following
SCI. Specifically, test performance in memory and executive functioning
domains were impacted relative to non-injured controls, with this effect
being considered of a moderate magnitude. A sub analysis in in-
dividuals with SCI ≥T6 and a history of unstable BP control revealed
moderate to large associations between cumulative orthostatic
hypotension symptom burden and cognitive function. These associa-
tions were observed in the cognitive domains of attention/concentration/
psychomotor speed and executive function and were also apparent when
all symptoms of BP instability were combined.
Our findings are consistent with previous studies looking at cogni-
tion in hypotensive individuals with SCI. For example, Jegede et al.
demonstrated significantly reduced memory and moderately reduced
attention and processing speed in participants with SCI, who were hy-
potensive over a 24-h period [23]. We have now extended these find-
ings to show that chronic symptomatic hypotension is linked with
cognitive impairment. Cerebral blood flow is regulated by a number of
factors including dynamic cerebral autoregulation, cerebrovascular re-
activity to changes in arterial blood gas tension, and neurovascular
coupling. In high-level SCI unstable cerebral perfusion occurs due to
alteration in these regulatory systems [26]. Consequently, cere-
brovascular reserve, which reflects the capacity of the cere-
brovasculature to maintain adequate blood flow when faced with a
decreased perfusion pressure [42], is negatively impacted. In turn, a
decline in cerebrovascular reserve will inhibit the capacity for neuro-
vascular coupling to appropriately link neuronal metabolism to cerebral
blood flow, and decreased cognitive function may occur as a result
[43]. It is conceivable that breakdown of these cerebrovascular reg-
ulatory systems after SCI may also underlie the up-to four-fold in-
creased risk of stroke in this population [44]. We have shown pre-
viously that when BP was increased in individuals with SCI by using
midodrine hydrochloride, an alpha-1 agonist it translated to a 70%
improvement in neurovascular coupling [45]. This was reflected by a
significant improvement in cognitive function as measured by COWAT.
After combining the symptoms for both orthostatic hypotension and
autonomic dysreflexia it was evident that unstable fluctuations in sys-
temic BP are associated with widespread cognitive dysfunction. These
conditions can happen multiple times over a 24-h period, in the same
individuals with SCI ≥T6 [28], which in extreme cases predispose the
cerebrovasculature to an acute hemodynamic insult or in less severe
cases, repetitive, cumulative insults may lead to cerebrovascular dys-
function through hyper and hypo-perfusion. Interestingly, recent cross-
sectional evidence from our laboratory suggests central arterial stiff-
ness, assessed via carotid-to-femoral pulse wave velocity (cfPWV), was
associated with the severity and frequency of objectively measured
hypotensive events (using 24-h ABPM) but not autonomic dysreflexia
[46]. However, similar to the findings presented herein, the strongest
association (r = =0.445, P = =0.02) was observed between cfPWV
and combined total autonomic dysreflexia and hypotensive events.
These data suggest that BP instability plays a role in arterial stiffening.
Such systemic changes are likely to permeate to the cerebrovasculature
and it is therefore not surprising that evidence in the able-bodied lit-
erature has associated cognitive deficits with increased arterial stiffness
[47–49]. It is worth noting that while individuals with SCI below T6 do
not experience such widespread BP fluctuations, evidence still suggests
a high prevalence of arterial stiffness [50,51], perhaps as a result of
physical inactivity [52,53]. Therefore, alterations in vascular mor-
phology may explain the reduced cognitive performance in those par-
ticipants with injuries below T6 without a history of unstable BP control
included in the SCI cohort.
Significant associations were not observed with autonomic dysre-
flexia symptom burden alone. Autonomic dysreflexia is characterized
by transient hypertensive episodes, which have been shown to acutely
insult cerebral blood vessels [27,54,55]. Chronic hypertension in able-
bodied individuals is strongly associated with cognitive decline, en-
compassing essentially the entire spectrum of cognitive domains in-
cluding learning and memory, attention, abstract reasoning, executive
function, as well as visuospatial, perceptual and psychomotor abilities
[56–58]. Preliminary evidence in rodent models suggests that chronic
exposure to repetitive transient hypertension after SCI leads to impaired
cerebrovascular functioning of the middle cerebral artery and profi-
brotic cerebrovascular remodeling [29]. Interestingly, these changes
Table 3
Associations between neurocognitive function outcomes and cumulative (fre-
quency multiplied by severity) autonomic dysreflexia, orthostatic hypotension
and total BP instability symptoms for individuals with spinal cord injury at or
above the 6th thoracic level (n = 19).











−0.226 .177 −0.247 .154 −0.196 .210
RAVLT, recall after
interference (n)
−0.277 .126 −0.096 .348 −0.096 .348
RAVLT, loss after
interference (n)
0.258 .118 −0.125 .305 −0.077 .378
RAVLT, long delay
free recall (n)
−0.252 .149 −0.196 .210 −0.232 .170
RAVLT, recognition
(n)
−0.091 .356 −0.060 .404 .029 .453
Attention/concentration/psychomotor speed
DS, forward (n) .123 .308 −0.026 .459 −0.052 .416
DS, backward (n) .046 .425 −0.016 .473 −0.015 .475
DS, score (n) .098 .346 .068 .391 .056 .411
TMT, A (s) .375 .057 .314 .095 .441 .029*
Stroop Test P2 (s) −0.008 .488 .448 .027* .330 .084
Stroop Test P3 (s) .187 .222 .506 .014* .434 .032*
Stroop Test P3-P2
(s)
.176 .236 .244 .157 .330 .084
Executive Function
TMT, B (s) .188 .221 .499 .015* .433 .032*
TMT, B-A (s) .213 .191 .485 .018* .398 .046
SDMT (n) .192 .215 .084 .366 .155 .264
COWAT (n) −0.018 .471 −0.020 .467 −0.055 .411
⁎ P < 0.05. Abbreviations: COWAT, Controlled Oral Word Association Test;
DS, Digit Span; RAVLT, Rey Auditory Verbal Learning Test; SDMT, Symbol Digit
Modalities Test; TMT, Trail Making Test.
T.E. Nightingale, et al. Physiology & Behavior 213 (2020) 112742
4
occurred in the absence of other hallmark cerebrovascular changes (i.e.
hypertrophic inward remodeling or reduced cerebral blood flow) as-
sociated with chronic steady-state hypertension [59]. It is possible the
transient nature of autonomic dysreflexia may present a different me-
chanistic effect on cerebrovascular remodeling than chronic hyperten-
sion. Further research is necessary to elucidate these differences.
4.1. Limitations
This study provides compelling, yet observational, cross-sectional
data highlighting associations between symptoms of unstable BP and
impaired cognitive function in individuals with SCI ≥T6. Individuals
with higher-level SCI who are predisposed to drastic BP fluctuations are
likely to be less physically active and experience other secondary co-
morbidities (i.e. sleep apnea, major depressive disorder, fatigue and
impaired glucose tolerance), which may confound the findings of this
study [60–63]. Sleep apnea is present in up to 50% of individuals with
high-level SCI [64], while depression also affects a large proportion of
this population [65]. Although significant differences were noted be-
tween groups for symptoms of depression, the group means for the BDI-
II are both considered to be within the ‘none or minimal depression’ range
(0 – 13), indicating non-clinically meaningful differences. We recognize
that side effects from pharmacological agents used to manage sec-
ondary complications following SCI (i.e. antimuscarinics for the treat-
ment of lower urinary tract dysfunctions and gabapentin to treat neu-
ropathic pain) can also impair cognitive function [66,67]. While not
captured in this present study, it has previously been demonstrated that
individuals with SCI are prescribed significantly more medications than
non-injured counterparts [68] and the potential impact of these drug-
drug interactions on cognitive functioning is currently unclear. Future
research should consider assessing and controlling for these con-
founding variables in analyses or study designs to determine the spe-
cific factors linked with cognitive decline in this population.
The adapted version of the ADFSCI questionnaire may require re-
finement. While the reported frequency of autonomic dysreflexia from
the ADFSCI questionnaire is closely associated with hypertensive events
ascertained from 24-h ABPM, the frequency and severity of orthostatic
hypotension symptoms were not significantly associated with objec-
tively measured episodes of hypotension [28]. Therefore, specific
symptoms relating to orthostatic hypotension (i.e. nausea, passing out
and lightheadedness) may represent other undiagnosed conditions or
underlying pathologies that are linked to cognitive impairment besides
hypotensive episodes alone. Moreover, not all episodes of autonomic
dysreflexia present with immediate critical emergencies. Many episodes
can be silent and are therefore undetected by the individual. In light of
this, researchers should consider using objective measurement methods
to quantify the frequency and severity of unstable BP episodes and
determine the interplay with cognitive functioning in individuals with
SCI.
5. Conclusions
Diverse cognitive dysfunction is shown in individuals with SCI
without a history of TBI relative to age and sex matched non-injured
controls. Significant associations are demonstrated between orthostatic
hypotension symptom burden and neurocognitive test performance for
participants with injuries ≥T6 and a history of unstable BP control,
further implicating this condition in the etiology of cognitive impair-
ments in this specific population. However, we caveat that these data
are taken from a self-report questionnaire and follow-up work should be
conducted with objective monitoring techniques, such as 24-h ABPM to
replicate these observations. Future studies are needed to examine
whether impaired cerebrovascular function is the mechanism linking
aberrant systemic BP changes with cognitive decline in humans fol-
lowing SCI. Rigorous, longitudinal cohort studies are necessary to elu-
cidate the underlying causality of cognitive deficits commonly observed
in this population. Animal models should also be employed to develop a
deeper mechanistic insight into the impact of unstable BP overtime and
subsequent cerebrovascular insults, such as blood-brain barrier break-
down and other brain pathologies (i.e. white matter hyperintensities,
lacunar infarcts, gray matter atrophy etc.), and how these link to cog-
nitive impairments in individuals with SCI.
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